Atrial natriuretic peptide inhibits angiotensin II‐stimulated proliferation in fetal cardiomyocytes
- 3 August 2010
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 588 (15), 2879-2889
- https://doi.org/10.1113/jphysiol.2010.191098
Abstract
The role of atrial natriuretic peptide (ANP) in regulating fetal cardiac growth is poorly understood. Angiotensin II (Ang II) stimulates proliferation in fetal sheep cardiomyocytes when growth is dependent on the activity of the mitogen-activated protein kinase (MAPK) and phosphoinositol-3-kinase (PI3K) pathways. We hypothesized that ANP would suppress near-term fetal cardiomyocyte proliferation in vitro and inhibit both the MAPK and PI3K pathways. Forty-eight hour 5-bromodeoxyuridine (BrdU) uptake (used as an index of proliferation) was measured in cardiomyocytes isolated from fetal sheep (135 day gestational age) in response to 100 nm Ang II with or without ANP (0.003-100 nm) or 1 microm 8-bromo-cGMP. The effects of these compounds on the MAPK and PI3K pathways were assessed by measuring extracellular signal-regulated kinase (ERK) and AKT phosphorylation following 10 min of treatment with Ang II, ANP or 8-bromo-cGMP. In right ventricular myocytes (RV), the lowest dose of ANP (0.003 nm) inhibited Ang II-stimulated BrdU uptake by 68%. Similarly, 8-bromo-cGMP suppressed Ang II-stimulated proliferation by 62%. The same effects were observed in left ventricular (LV) cardiomyocytes but the RV was more sensitive to the inhibitory effects of ANP than the LV (P < 0.0001). Intracellular cGMP was increased by 4-fold in the presence of 100 nm ANP. Ang II-stimulated ERK and Akt phosphorylation was inhibited by 100 nm ANP. The activity of ANP may in part be cGMP dependent, as 8-bromo-cGMP had similar effects on the cardiomyocytes.This publication has 61 references indexed in Scilit:
- Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanismCardiovascular Research, 2009
- Natriuretic peptide C receptor signalling in the heart and vasculatureThe Journal of Physiology, 2008
- Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Giα protein/MAP kinase/PI3-kinase/AKT pathwaysAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Mitogen-activated protein kinase activation and regulation in the pressure-loaded fetal ovine heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1Biochemical and Biophysical Research Communications, 2004
- Angiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytesThe Journal of Physiology, 2003
- Natriuretic Peptide Receptor-A Negatively Regulates Mitogen-Activated Protein Kinase and Proliferation of Mesangial Cells: Role of cGMP-Dependent Protein KinaseBiochemical and Biophysical Research Communications, 2000
- Atrial Natriuretic Peptide Inhibits Endothelin-1-Induced Activation of Mitogen-Activated Protein Kinase in Cultured Rat Mesangial CellsBiochemical and Biophysical Research Communications, 1993
- Biological Receptors Mediate Anti-proliferative Action of Atrial Natriuretic Peptide in Cultured Mesangial CellsBiochemical and Biophysical Research Communications, 1993
- Inhibition by Atrial Natriuretic Peptide of Endothelin-1-Stimulated Proliferation of Vascular Smooth-Muscle CellsJournal of Cardiovascular Pharmacology, 1993